Dermorphin (5 mg Vial) Dosage Protocol
Dermorphin is a 7-amino-acid opioid peptide originally isolated from the skin of South American tree frogs. It is a potent mu-opioid receptor agonist studied for analgesia.
⚡ Quickstart Highlights
Dosing & Reconstitution Guide
Route: Subcutaneous | Frequency: As needed (research) | Half-life: ~30 minutes
Standard Approach (3 mL = 1.67 mg/mL)
Reconstituting with 3 mL bacteriostatic water produces a concentration of 1.67 mg/mL. Volume per dose changes with concentration; mg dose itself does not change between vial sizes.
| Phase / Protocol | Dose | U-100 Units | Volume | Doses per vial |
|---|---|---|---|---|
| Research | 50 mcg | 3 units | 0.030 mL | 100 doses |
Reconstitution Steps
- Wipe the vial stopper and BAC water vial with alcohol; let dry.
- Draw 3 mL of bacteriostatic water into a sterile syringe.
- Inject slowly down the inside glass wall of the peptide vial. Do not aim at the powder.
- Gently swirl until fully dissolved. Do not shake.
- Label with reconstitution date. Refrigerate at 2–8°C; use within 30 days.
Supplies Needed
Estimates for an 8-week and 12-week cycle at 50 mcg per dose, as needed (research) (7 doses/week).
| Item | 8-Week Cycle | 12-Week Cycle |
|---|---|---|
| Dermorphin (5 mg) vials | 1 vials | 1 vials |
| Insulin syringes (U-100) | 56 | 84 |
| Bacteriostatic water (10 mL) | 1 × 10 mL | 1 × 10 mL |
| Alcohol swabs | 1 × 100-pack | 2 × 100-pack |
Protocol Overview
Dermorphin is a potent mu-opioid agonist with significant abuse and overdose potential. Strictly research-only with extreme dosing accuracy required.
Dosing Protocol
Conservative research dosing only:
- Research (50 mcg): Conservative — high potency requires extreme care.
No standard cycle structure — research protocols only.
Storage Instructions
| State | Temperature | Duration |
|---|---|---|
| Lyophilized | −20°C (−4°F) | Up to 24 months, dry & dark |
| Reconstituted | 2–8°C (35–46°F) | Up to 30 days, protect from light |
Important Notes
How This Works
Dermorphin is a heptapeptide containing a D-amino acid (D-Ala in position 2) — unusual among biologically active peptides. It binds the mu-opioid receptor with very high affinity, producing analgesia roughly 30–40× more potent than morphine on a molar basis.
Potential Benefits & Side Effects
Potential Benefits
- Potent analgesia in animal models.
- Long-duration effect compared to morphine.
- Studied in pain pathophysiology research.
Side Effect Profile
- Standard opioid risks: respiratory depression, dependence, tolerance, sedation.
- High potency requires extreme dosing accuracy in research.
- Significant abuse and overdose potential.
Lifestyle Factors
- Compound is potent — research handling requires extreme care.
Injection Technique
- Subcutaneous in research; route varies by protocol.